Chengdu Kanghua Biological Products Co., Ltd.
SZSE:300841.SZ
64.68 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| 509.216 | 598.066 | 829.478 | 408.046 | 186.687 | 154.14 | 74.458 | 6.658 | 11.702 |
| Depreciation & Amortization
| 61.771 | 32.575 | 16.532 | 12.26 | 9.079 | 9.34 | 9.725 | 9.966 | 10.186 |
| Deferred Income Tax
| -1.459 | 6.27 | -1.857 | 0.123 | 0.337 | -0.24 | 4.448 | -1.057 | 3.227 |
| Stock Based Compensation
| -3.958 | 1.858 | 8.902 | 10.765 | 18.665 | 21.873 | 0 | 0 | 0 |
| Change In Working Capital
| -39.661 | -438.143 | -469.9 | -61.591 | -37.073 | -137.341 | 1.466 | -35.416 | -29.836 |
| Accounts Receivables
| -113.841 | -448.908 | -535.229 | -102.151 | -25.86 | -154.051 | -25.951 | -42.136 | -7.037 |
| Inventory
| -21.521 | -56.859 | -57.532 | -1.257 | -16.036 | -6.337 | -4.14 | -6.675 | -20.265 |
| Accounts Payables
| 95.701 | 61.354 | 124.717 | 41.694 | 4.486 | 23.287 | 27.108 | 14.452 | -5.761 |
| Other Working Capital
| -3.958 | 6.27 | -1.857 | 0.123 | 0.337 | -131.004 | 5.605 | -28.741 | -9.571 |
| Other Non Cash Items
| 207.668 | 2.492 | -245.783 | 10.849 | 24.037 | 31.216 | 4.308 | 21.435 | 14.453 |
| Operating Cash Flow
| 574.332 | 194.991 | 130.326 | 369.564 | 182.73 | 57.355 | 89.956 | 2.643 | 6.505 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -157.275 | -419.226 | -314.939 | -135.668 | -24.035 | -34.581 | -4.531 | -1.855 | -3.071 |
| Acquisitions Net
| 0.037 | 0.002 | 0.01 | 135.716 | 0.066 | 0.004 | 0.148 | 0 | 0 |
| Purchases Of Investments
| -56.5 | -210 | -850.25 | -592.5 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 50 | 216.766 | 963.651 | 286.723 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -6.115 | 0 | 0 | -135.668 | 0 | 0.004 | 0.148 | -1.855 | -3.071 |
| Investing Cash Flow
| -163.738 | -412.459 | -201.528 | -441.398 | -23.969 | -34.577 | -4.383 | -1.855 | -3.071 |
| Financing Activities: | |||||||||
| Debt Repayment
| -64.829 | -30 | 0 | -10 | -32.5 | -7.5 | -229.163 | 0 | 0 |
| Common Stock Issued
| 0 | 67.213 | 0 | 985.985 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -67.213 | -55.884 | -985.985 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -66.874 | -133.776 | -90 | -0.231 | -0.533 | -5.942 | -21.27 | 0 | 0 |
| Other Financing Activities
| -4.76 | 93.256 | -1.512 | 985.985 | 23.5 | 20.446 | 217.625 | 0 | 0 |
| Financing Cash Flow
| -7.117 | -73.565 | -147.396 | 975.754 | -9.533 | 7.004 | -32.808 | 0 | 0 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| -0.069 | 0.113 | -0.014 | -0.062 | 0.049 | -0.001 | -0.037 | 0.008 | 0.013 |
| Net Change In Cash
| 387.903 | -290.92 | -218.613 | 903.858 | 149.276 | 29.782 | 52.729 | 0.796 | 3.448 |
| Cash At End Of Period
| 1,039.366 | 635.958 | 926.879 | 1,145.491 | 241.633 | 92.357 | 62.575 | 9.846 | 9.051 |